BRIEF published on 07/26/2024 at 07:35, 2 years ago HENSOLDT annonce de solides performances financières au premier semestre 2024 Rentabilité HENSOLDT Hausse Des Revenus Prises De Commandes Électronique De Défense
BRIEF published on 07/26/2024 at 07:35, 2 years ago HENSOLDT Announces Strong Financial Performance in First Half of 2024 Revenue Growth Profitability Order Intake HENSOLDT Defense Electronics
PRESS RELEASE published on 07/26/2024 at 07:30, 2 years ago HENSOLDT with strong order intake and increased profitability in the first half of 2024 HENSOLDT reports strong order intake and increased profitability in the first half of 2024. Revenue up 17.0% to EUR 849 million. Adjusted EBITDA rises by 26.2% to EUR 103 million EBITDA Revenue Profitability Order Intake HENSOLDT
BRIEF published on 07/10/2024 at 18:19, 2 years ago Celia Pelaz démissionne du conseil d'administration de HENSOLDT AG Conseil D'administration Démission Conseil De Surveillance HENSOLDT Celia Pelaz
BRIEF published on 07/10/2024 at 18:19, 2 years ago Celia Pelaz Resigns from HENSOLDT AG Management Board Resignation Supervisory Board Management Board HENSOLDT Celia Pelaz
PRESS RELEASE published on 07/10/2024 at 18:14, 2 years ago Celia Pelaz resigns from the Management Board of HENSOLDT AG Celia Pelaz resigns from the Management Board of HENSOLDT AG by mutual consent. Supervisory Board praises her significant contributions. Operational excellence remains top priority for Management Board Operational Excellence Resignation Supervisory Board Management Board HENSOLDT AG
BRIEF published on 05/07/2024 at 07:35, 2 years 3 months ago HENSOLDT annonce un premier trimestre 2024 solide avec une augmentation des prises de commandes HENSOLDT Hausse Des Revenus Rapport Sur Les Revenus Prises De Commandes Industrie De La Défense
BRIEF published on 05/07/2024 at 07:35, 2 years 3 months ago HENSOLDT Reports Strong First Quarter in 2024 with Surge in Order Intake Revenue Growth Earnings Report Order Intake HENSOLDT Defense Industry
PRESS RELEASE published on 05/07/2024 at 07:30, 2 years 3 months ago HENSOLDT continues positive business development in the first quarter of 2024 and benefits from strong order intake HENSOLDT reports positive business development in Q1 2024 with 91.8% order intake growth to EUR 665 million and record high order backlog of EUR 5,879 million Acquisition Financial Results Business Development Order Intake HENSOLDT
BRIEF published on 04/03/2024 at 07:35, 2 years 4 months ago HENSOLDT acquiert ESG, renforçant ainsi ses capacités d'électronique de défense et d'intégration de systèmes Acquisition ESG HENSOLDT Électronique De Défense Systeme D'intégration
Published on 08/10/2026 at 08:00, 2 hours 34 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 34 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 11 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 10:12, 22 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/10/2026 at 10:10, 24 minutes ago Hana Bank Subsidiary GLN Expands QR Payment Network for International Travelers to Korea
Published on 08/10/2026 at 09:50, 44 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 34 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 34 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:22, 1 hour 12 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 1 hour 12 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 34 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 34 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
